Mechanism of Action
WELIREG (belzutifan) is an inhibitor of hypoxia-inducible factor 2 alpha (HIF-2α)
Under normal oxygen levels, HIF-2α is targeted for degradation by VHL protein
HIF-2α translocates into the nucleus and interacts with hypoxia-inducible factor 1 beta (HIF-1β)